You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: July 24, 2024

MESNEX Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Mesnex patents expire, and what generic alternatives are available?

Mesnex is a drug marketed by Baxter Hlthcare and is included in two NDAs.

The generic ingredient in MESNEX is mesna. There are ten drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the mesna profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Mesnex

A generic version of MESNEX was approved as mesna by FRESENIUS KABI USA on April 26th, 2001.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for MESNEX?
  • What are the global sales for MESNEX?
  • What is Average Wholesale Price for MESNEX?
Drug patent expirations by year for MESNEX
Drug Prices for MESNEX

See drug prices for MESNEX

Recent Clinical Trials for MESNEX

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Markus MaparaPhase 1/Phase 2
ITB-Med LLCPhase 1/Phase 2
Center for International Blood and Marrow Transplant ResearchPhase 1/Phase 2

See all MESNEX clinical trials

Pharmacology for MESNEX

US Patents and Regulatory Information for MESNEX

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Baxter Hlthcare MESNEX mesna INJECTABLE;INTRAVENOUS 019884-001 Dec 30, 1988 AP RX Yes Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Baxter Hlthcare MESNEX mesna TABLET;ORAL 020855-001 Mar 21, 2002 RX Yes Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for MESNEX

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Baxter Hlthcare MESNEX mesna INJECTABLE;INTRAVENOUS 019884-001 Dec 30, 1988 ⤷  Sign Up ⤷  Sign Up
Baxter Hlthcare MESNEX mesna TABLET;ORAL 020855-001 Mar 21, 2002 ⤷  Sign Up ⤷  Sign Up
Baxter Hlthcare MESNEX mesna TABLET;ORAL 020855-001 Mar 21, 2002 ⤷  Sign Up ⤷  Sign Up
Baxter Hlthcare MESNEX mesna INJECTABLE;INTRAVENOUS 019884-001 Dec 30, 1988 ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

International Patents for MESNEX

See the table below for patents covering MESNEX around the world.

Country Patent Number Title Estimated Expiration
Austria 104548 ⤷  Sign Up
Finland 97949 ⤷  Sign Up
Ireland 47609 PROCESS FOR PRODUCING DETOXIFIED PHARMACEUTICAL PRODUCTS CONTAINING A CYTOSTATICALLY ACTIVE ALKYLATING AGENT ⤷  Sign Up
Austria 358162 ⤷  Sign Up
Canada 2107961 SOLUTIONS MESNA INJECTABLES (INJECTABLE MESNA SOLUTIONS) ⤷  Sign Up
>Country >Patent Number >Title >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.